🕵️ Benitec Biopharma Inc. ($BNTC)
SEC insider & ownership activity, last 12 months · CIK 1808898 · every row links its SEC filing
Over the last 12 months insiders bought $22.4M with no open-market selling against it. Suvretta Capital Management, LLC bought $22.4M (Nov–Dec). Suvretta Capital Management, LLC trimmed 49.9% → 44.1%; Averill Master Fund, Ltd. trimmed 44.5% → 37.8%. One red-flag 8-K in the window: Restatement (4.02), Sep 10, 2025.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $22.4M (14 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | 14 | $22.4M | 0 | – | Dec 29, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Aaron Cowen | 44.1% | 13D | Nov 7, 2025 | filing ↗ | |
| Suvretta Capital Management, LLC | 44.1% | 13D | Nov 7, 2025 | filing ↗ | |
| Averill Master Fund, Ltd. | 37.8% | 13D | Nov 7, 2025 | filing ↗ | |
| Franklin Resources, Inc. | 10.6% | 13G | Jan 29, 2026 | filing ↗ | |
| Franklin Advisers, Inc. | 10.6% | 13G | Jan 29, 2026 | filing ↗ | |
| Janus Henderson Group PLC | 10.0% | 13G | Dec 8, 2025 | filing ↗ | |
| Averill Madison Master Fund, Ltd. | 6.3% | 13D | Nov 7, 2025 | filing ↗ | |
| Janus Henderson Biotech Innovation Master Fund Ltd | 6.1% | 13G | Dec 8, 2025 | filing ↗ | |
| RA Capital Management, L.P. | 5.5% | 13G | Dec 3, 2025 | filing ↗ | |
| Peter Kolchinsky | 5.5% | 13G | Dec 3, 2025 | filing ↗ | |
| Rajeev Shah | 5.5% | 13G | Dec 3, 2025 | filing ↗ | |
| RA Capital Healthcare Fund, L.P. | 5.5% | 13G | Dec 3, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | May 22, 2026 | filing ↗ |
| Earnings (2.02) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Earnings (2.02) | Feb 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 12, 2026 | filing ↗ |
| Shareholder vote (5.07) | Dec 1, 2025 | filing ↗ |
| Earnings (2.02) | Nov 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 14, 2025 | filing ↗ |
| Material agreement (1.01) | Nov 5, 2025 | filing ↗ |
| Other events (8.01) | Nov 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 5, 2025 | filing ↗ |
| Officer/director changes (5.02) | Nov 2, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 2, 2025 | filing ↗ |
| Other events (8.01) | Nov 2, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 2, 2025 | filing ↗ |
| Earnings (2.02) | Sep 22, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 22, 2025 | filing ↗ |
| Restatement (4.02) | Sep 10, 2025 | filing ↗ |